Pulmonary Fibrosis

9 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Lung Diseases, Lung Diseases, Interstitial

Narrower: Idiopathic Pulmonary Fibrosis 7

Treatments and conditions

Pulmonary Fibrosis
Treatment and conditionWhere it standsTrials
BC006 for idiopathic pulmonary fibrosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Belumosudil 200 mg QD for pulmonary fibrosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Bersiporocin for idiopathic pulmonary fibrosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
CAL101 for idiopathic pulmonary fibrosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Colchicine 0.5 mg for pulmonary fibrosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
HB0056 for idiopathic pulmonary fibrosisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
HSK44459 for idiopathic pulmonary fibrosisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Rentosertib for idiopathic pulmonary fibrosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Taladegib for idiopathic pulmonary fibrosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.